NEW YORK, May 6 (GenomeWeb News) -- Shares of Harvard Bioscience were down 10.82 percent, or $.42, at $3.46 in mid-afternoon trading after the company yesterday reported a 1-percent increase in revenues and a small net profit for the first quarter of 2005.
Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.
